Clinical Trials Logo

Clinical Trial Summary

The masseter muscle is one of the muscles in the lower face used for chewing. Prominence of the masseter muscle can appear as a widened and square lower face shape, which is an aesthetic concern for individuals who prefer a narrower and more ovoid lower face shape. Treatments are available for masseter muscle prominice (MMP), but researchers are looking for new non-surgical treatments. This study will assess adverse events and effectiveness of BOTOX in adult participants with MMP. BOTOX is being investigated for the treatment of MMP. Participants are placed in 1 of 2 groups, called treatment arms. Each group receives a different treatment. There is 1 in 4 chance that participants will be assigned to placebo. Around 248 adult participants with MMP will be enrolled in the study at approximately 30 sites in Europe. Participants will receive either BOTOX or Placebo administered as 6 intramuscular injections to the masseter on Day 1. Participants who are eligible for retreatment will be given BOTOX on Day 180 and will be followed for up to 6 months. There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, checking for side effects and completing questionnaires.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06068855
Study type Interventional
Source AbbVie
Contact ABBVIE CALL CENTER
Phone 844-663-3742
Email abbvieclinicaltrials@abbvie.com
Status Recruiting
Phase Phase 3
Start date October 17, 2023
Completion date November 25, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT06137287 - A Study to Assess Adverse Events and Change of Masseter Muscle Prominence Using BOTOX Injections in Adult Participants Phase 3
Completed NCT03861936 - BOTOX® (onabotulinumtoxinA) Treatment of Masseter Muscle Prominence Phase 2
Completed NCT04073303 - BOTOX® Treatment for Adults With a Wide Lower Face Due to Masseter Muscle Prominence Phase 3
Recruiting NCT06399718 - A Study to Assess BOTOX Injections for the Change of Masseter Muscle Prominence in Adult Participants Phase 3
Recruiting NCT06387394 - A Study to Assess BOTOX Injections in Adult Participants for the Change of Masseter Muscle Prominence Phase 3